---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-016408"
form_type: "8-K"
ticker: "OSTX"
cik: "0001795091"
company_name: "OS Therapies Inc"
filed_at: "2026-02-13T23:59:59+00:00"
generated_at: "2026-05-16T02:48:30.539822+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# OS Therapies extends warrant exercise inducement period to March 2, 2026

## Summary
- Company extended offering period for warrant inducement from Feb 10 to March 2, 2026.
- Existing Warrants covering up to 5,382,148 shares may be exercised at $1.40 per share.
- Exercise triggers issuance of new warrants for same number of shares at $1.40 per share.
- Extension consented to by company’s warrant solicitation agent.

## SEC filing metadata
- accession: 0001213900-26-016408
- form_type: 8-K
- ticker: OSTX
- cik: 0001795091
- company_name: OS Therapies Inc
- filed_at: 2026-02-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1795091/000121390026016408/0001213900-26-016408-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1795091/000121390026016408/ea0276846-8k_ostherap.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-016408
- JSON: https://secwatch.observer/filing/0001213900-26-016408.json
- Plain text: https://secwatch.observer/filing/0001213900-26-016408.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.